O. Sitbon (Clamart, France), M. Kneussl (Vienna, Austria)
Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol
J. Behr, R. Baumgartner, M. Borst, R. Ewert, A. Ghofrani, M. Höper, A. Meyer, S. Nikkho, H. Olschewski, S. Singer, E. Spiekerkoetter, H. Wilkens, J. Winkler, W. Seeger (Giessen, Berlin, Germany)
|  |
Acute effects, 1-year, and 2-year follow up of iloprost-aerosol therapy in severe primary pulmonary hypertension
R. Baumgartner, H. Leuchte, T. Kolbe, M. Schwaiblmair, J. Behr (Munich, Germany)
| |
Inhaled iloprost plus oral sildenafil in patients with pulmonary hypertension
H. Wilkens, A. Groeschel-Guth, J. Koenig, N. Forestier, M. Boehm, G. W. Sybrecht (Homburg, Germany)
| |
Co-application of oxygen improves iloprost inhalation in pulmonary hypertension patients with long-term oxygen therapy
T. Gessler, T. Schmehl, F. Rose, H. Olschewski, W. Seeger (Giessen, Germany)
| |
One-year observation of iloprost inhalation therapy in patients with pulmonary hypertension
S. Nikkho, W. Seeger, R. Baumgartner, J. Behr, M. Borst, R. Ewert, H. Ghofrani, M. Höper, A. Meyer, H. Siedentop, E. Spiekerkoetter, H. Wilkens, J. Winkler, H. Olschewski (Berlin, Giessen, Germany)
| |
Effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise
F. C. Blumberg, G. A. J. Riegger, M. Pfeifer (Regensburg, Germany)
| |
Nebulised Iloprost for pulmonary arterial hypertension associated with congenital heart disease: one centre's experience
R. J. Allcock, M. B. Day, S. Adwani, H. H. Bain, P. A. Corris (Newcastle upon Tyne, United Kingdom)
| |
Efficacy of epoprostenol treatment for pulmonary hypertension: hemodynamic and clinical improvement during the initial 8-month period
R. J. Roeleveld, A. Vonk Noordegraaf, J. T. Marcus, P. E. Postmus, A. Boonstra (Amsterdam, The Netherlands)
| |